Latest research report on “Neuromodulation Devices And Implantable Infusion Pumps Market” now available at high quality database of ReportsnReports.com with market size, share, trends, competitive and statistical analysis. An exclusive data offered in this report is collected by research and industry experts team.
Get Free Sample Copy @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5546084
An implantable infusion pump (IIP) is intended to provide long-term continuous or intermittent drug infusion. Possible routes of administration include intravenous, intra-arterial, subcutaneous, intraperitoneal, intrathecal, epidural, and intraventricular. The IIP is surgically placed in a subcutaneous pocket under the infraclavicular fossa or in the abdominal wall, and a catheter is threaded into the desired position.
This report contains market size and forecasts of Neuromodulation Devices and Implantable Infusion Pumps in global, including the following market information:
Global Neuromodulation Devices and Implantable Infusion Pumps Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Neuromodulation Devices and Implantable Infusion Pumps Market Sales, 2017-2022, 2023-2028, (Unit)
Global top five Neuromodulation Devices and Implantable Infusion Pumps companies in 2021 (%)
The global Neuromodulation Devices and Implantable Infusion Pumps market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Spinal Cord Stimulation Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Neuromodulation Devices and Implantable Infusion Pumps include Medtronic, Boston Scientific Corporation, St. Jude Medical, Synapse Biomedical, Nevro Corporation, Neuropace, Cyberonics, Autonomic Technologies and Avery Biomedical and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Neuromodulation Devices and Implantable Infusion Pumps manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Neuromodulation Devices and Implantable Infusion Pumps Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Unit)
Global Neuromodulation Devices and Implantable Infusion Pumps Market Segment Percentages, by Type, 2021 (%)
– Spinal Cord Stimulation
– Deep Brain Stimulation
– Sacral Nerve Stimulation
– Vagal Nerve Stimulation
– Gastric Stimulation
– Transcranial Magnetic Stimulation
– Transcutaneous Electrical Stimulation
– Other
Global Neuromodulation Devices and Implantable Infusion Pumps Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Unit)
Global Neuromodulation Devices and Implantable Infusion Pumps Market Segment Percentages, by Application, 2021 (%)
– Parkinson’s Disease
– Epilepsy
– Pain
– Other
Global Neuromodulation Devices and Implantable Infusion Pumps Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Unit)
Global Neuromodulation Devices and Implantable Infusion Pumps Market Segment Percentages, By Region and Country, 2021 (%)
– North America
– – US
– – Canada
– – Mexico
– Europe
– – Germany
– – France
– – U.K.
– – Italy
– – Russia
– – Nordic Countries
– – Benelux
– – Rest of Europe
– Asia
– – China
– – Japan
– – South Korea
– – Southeast Asia
– – India
– – Rest of Asia
– South America
– – Brazil
– – Argentina
– – Rest of South America
– Middle East & Africa
– – Turkey
– – Israel
– – Saudi Arabia
– – UAE
– – Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Neuromodulation Devices and Implantable Infusion Pumps revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Neuromodulation Devices and Implantable Infusion Pumps revenues share in global market, 2021 (%)
Key companies Neuromodulation Devices and Implantable Infusion Pumps sales in global market, 2017-2022 (Estimated), (Unit)
Key companies Neuromodulation Devices and Implantable Infusion Pumps sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
– Medtronic
– Boston Scientific Corporation
– St. Jude Medical
– Synapse Biomedical
– Nevro Corporation
– Neuropace
– Cyberonics
– Autonomic Technologies
– Avery Biomedical
– Greatbatch Medical
More information about Discount offers (25% or More) @ https://www.reportsnreports.com/contacts/discount.aspx?name=5546084
About Us: ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.
We provide 24/7 online and offline support to our customers.
E-mail: [email protected]
Phone: +1 888 391 5441